Texas Instruments Incorporated (TXN)

Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.

Negative gross profit growth while MRVL is at 2.26%. Joel Greenblatt would examine cost competitiveness or demand decline.

EBIT growth below 50% of MRVL's 494.07%. Michael Burry would suspect deeper competitive or cost structure issues.

Negative operating income growth while MRVL is at 494.07%. Joel Greenblatt would press for urgent turnaround measures.

Negative net income growth while MRVL stands at 5309.05%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.

Negative EPS growth while MRVL is at 5354.55%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.

Negative diluted EPS growth while MRVL is at 4900.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.

Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.

Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.

10Y revenue/share CAGR under 50% of MRVL's 738.45%. Michael Burry would suspect a lasting competitive disadvantage.

Negative 5Y CAGR while MRVL stands at 285.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.

Negative 3Y CAGR while MRVL stands at 104.43%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.

10Y OCF/share CAGR under 50% of MRVL's 1062.91%. Michael Burry would worry about a persistent underperformance in cash creation.

Negative 5Y OCF/share CAGR while MRVL is at 167.81%. Joel Greenblatt would question the firm’s operational model or cost structure.

Negative 3Y OCF/share CAGR while MRVL stands at 75.23%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.

Negative 10Y net income/share CAGR while MRVL is at 946.12%. Joel Greenblatt sees a major red flag in long-term profit erosion.

Negative 5Y net income/share CAGR while MRVL is 1195.83%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.

Negative 3Y CAGR while MRVL is 2.09%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.

Below 50% of MRVL's 7959.39%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.

Below 50% of MRVL's 45.85%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.

Below 50% of MRVL's 27.11%. Michael Burry suspects a serious short-term disadvantage in building book value.

AR growth well above MRVL's 8.16%. Michael Burry fears inflated revenue or higher default risk in the near future.

Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.

Negative asset growth while MRVL invests at 1.30%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.

We have a declining book value while MRVL shows 1.82%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.

Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.